SANTA CRUZ, CALIFORNIA, USA, March 4, 2024 / EINPresswire.com / -- RealSeq offers comprehensive next-generation sequencing (NGS) workflows to advance transcriptomics, large-scale RNA sequencing and to ...
Zacks Investment Research on MSN
Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals
In the first nine months of 2025, Tempus AI Inc. TEM achieved several key regulatory milestones that strengthened its position in AI-driven diagnostics. In September 2025, the company received FDA 510 ...
Next-generation metagenomic sequencing test developed at UCSF proves its effectiveness in quickly diagnosing almost any kind of pathogen. A genomic test developed at UC San Francisco to rapidly detect ...
EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens ...
CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully RNA-encoded, site-specific gene-integration system, presented at the Cold ...
The webinar series titled "The Basics of Next Generation Sequencing and its Application in Precision Oncology" aims to provide a comprehensive understanding of the fundamentals and practical ...
SANTA CRUZ, CALIFORNIA, USA, March 4, 2024 / EINPresswire.com / -- RealSeq offers comprehensive next-generation sequencing (NGS) workflows to advance transcriptomics, large-scale RNA sequencing and to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback